# Skye Biologics Holdings LLC – FDA Inspection, Jun 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/skye-biologics-holdings-llc/5e084dc6-6742-4a83-8e7c-be432cf2865d
Source feed: FDA_Inspections

> FDA inspection 1056334 of Skye Biologics Holdings LLC, June 11, 2018. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056334
- Company Name: Skye Biologics Holdings LLC
- Inspection Date: 2018-06-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1106268 - 2019-09-25
- FDA Inspection 989083 - 2016-08-25
- FDA Inspection 920639 - 2015-02-02
- FDA Inspection 772820 - 2012-02-27
- [FDA Inspection 645189 - 2010-02-11](https://www.keypedia.com/records/fda_inspections/skye-biologics-holdings-llc/06288d23-5e01-4086-86ac-1b4b2bd84538)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/jennifer-l-custodio/489a8b9c-ab8d-4d37-b89c-6086889e825c)

Company: https://www.keypedia.com/companies/skye-biologics-holdings-llc/955a9fe7-05a2-4d51-b376-f37b83dd7928

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
